Unlearn.ai
Predict clinical trial outcomes using AI-powered patient digital twins
Business Intelligence · Predictive AnalyticsFree
Features
Digital Twins
AI-generated patient models predicting clinical outcomes with precision
Regulatory Alignment
EMA-qualified methods meeting FDA guidance requirements
Real-time Insights
Explore predicted outcomes for any subgroup at any time
Endpoint Optimization
Identifies most sensitive clinical outcomes for trials
Pricing
Pricing Model
N/A
Has free version
No
API access available
Not Available
Platform Support
Technical Information
SSL Secure
No
API Access
Not Available
DiscoveredInvalid Date
Frequently Asked Questions
How do digital twins improve clinical trials?
They predict individual patient outcomes using AI, allowing researchers to simulate trials and optimize study designs before recruiting real participants.
Is Unlearn's methodology regulator-approved?
Yes, their approach is qualified by the European Medicines Agency and aligns with FDA guidance for clinical trial design.
What diseases does Unlearn support?
Currently focuses on neuroscience (like Alzheimer's), immunology, and metabolic diseases, with expansion capabilities.
Social Media
Social Media